De Backer Marianne, CEO of Vir Biotechnology Inc. ($VIR), sold shares on the open market three times in the last year, totaling about $757 thousand. Her most recent sale occurred on February 24, 2026. These sales rank her 5,556th among 11,678 insiders in our database by total value sold, below the average of $8.6 million across 6.4 transactions per insider. She made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 24, 2026 | Vir Biotechnology, Inc. | $VIR | De Backer Marianne | Chief Executive Officer | S | Common Stock | 14762 | $9.53 | 1,073,822.0000 | 139,125,032 | 1.36% | 0.01% |
| Feb. 22, 2026 | Vir Biotechnology, Inc. | $VIR | De Backer Marianne | Chief Executive Officer | A | Common Stock | 285000 | $0.00 | 1,107,623.0000 | 139,125,032 | 34.65% | 0.20% |
| Feb. 22, 2026 | Vir Biotechnology, Inc. | $VIR | De Backer Marianne | Chief Executive Officer | A | Stock Option (Right to Buy) | 570000 | $0.00 | 570,000.0000 | 139,125,032 | 9999.99% | 0.41% |
| Feb. 23, 2026 | Vir Biotechnology, Inc. | $VIR | De Backer Marianne | Chief Executive Officer | S | Common Stock | 19039 | $7.45 | 1,088,584.0000 | 139,125,032 | 1.72% | 0.01% |
| April 3, 2025 | Vir Biotechnology, Inc. | $VIR | De Backer Marianne | Chief Executive Officer | S | Common Stock | 79712 | $5.95 | 822,623.0000 | 137,143,286 | 8.83% | 0.06% |
| Feb. 22, 2025 | Vir Biotechnology, Inc. | $VIR | De Backer Marianne | Chief Executive Officer | A | Stock Option (Right to Buy) | 480000 | $0.00 | 480,000.0000 | 137,143,286 | 9999.99% | 0.35% |
| Feb. 22, 2025 | Vir Biotechnology, Inc. | $VIR | De Backer Marianne | Chief Executive Officer | A | Common Stock | 240000 | $0.00 | 918,457.0000 | 137,143,286 | 35.37% | 0.18% |
| Feb. 24, 2025 | Vir Biotechnology, Inc. | $VIR | De Backer Marianne | Chief Executive Officer | S | Common Stock | 16122 | $9.45 | 902,335.0000 | 137,143,286 | 1.76% | 0.01% |
| June 12, 2024 | Vir Biotechnology, Inc. | $VIR | De Backer Marianne | Chief Executive Officer | J | Common Stock | 53118 | $0.00 | 678,457.0000 | 0 | 8.49% | 0.00% |
| June 12, 2024 | Vir Biotechnology, Inc. | $VIR | De Backer Marianne | Chief Executive Officer | J | Common Stock | 53118 | $0.00 | 678,457.0000 | 0 | 7.26% | 0.00% |
| April 3, 2024 | Vir Biotechnology, Inc. | $VIR | De Backer Marianne | Chief Executive Officer | S | Common Stock | 72995 | $9.46 | 678,457.0000 | 0 | 9.71% | 0.00% |
| Feb. 22, 2024 | Vir Biotechnology, Inc. | $VIR | De Backer Marianne | Chief Executive Officer | A | Stock Option (Right to Buy) | 350000 | $0.00 | 350,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 22, 2024 | Vir Biotechnology, Inc. | $VIR | De Backer Marianne | Chief Executive Officer | A | Common Stock | 175000 | $0.00 | 751,452.0000 | 0 | 30.36% | 0.00% |
| April 3, 2023 | Vir Biotechnology, Inc. | $VIR | De Backer Marianne | Chief Executive Officer | A | Stock Option (Right to Buy) | 1152904 | $0.00 | 1,152,904.0000 | 0 | 9999.99% | 0.00% |
| April 3, 2023 | Vir Biotechnology, Inc. | $VIR | De Backer Marianne | Chief Executive Officer | A | Common Stock | 576452 | $0.00 | 576,452.0000 | 0 | 9999.99% | 0.00% |